Effects of aging on mortality, hypothermia, and cytokine induction in mice with endotoxemia or sepsis

被引:136
作者
Saito, H [1 ]
Sherwood, ER
Varma, TK
Evers, BM
机构
[1] Univ Texas, Med Branch, Dept Surg, Galveston, TX 77555 USA
[2] Univ Texas, Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA
关键词
aging; cytokines; endotoxemia; hypothermia; sepsis;
D O I
10.1016/j.mad.2003.08.002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aging is accompanied by an altered stress response that underlies increased susceptibility of the elderly patients to physiological stress such as infection and sepsis. In the present study, we investigated the effects of aging on mortality, hypothermia, and cytokine induction in mouse models of intra-abdominal sepsis and endotoxemia. Systemic inflammation associated with either cecal ligation/puncture (CLP) or injection with bacterial endotoxin, lipopolysaccharide (LPS), resulted in a significantly elevated mortality rate in aged (24 months) compared to young (4 months) mice. The aged mice also showed profound hypothermia during these inflammatory stresses; IN: severity of hypothermia at the early phase of sepsis or endotoxemia could predict the mortality of individual animals. The stress-mediated induction of interleukin-1beta, interleukin-6, and interleukin-10 (IL-1beta, IL-6, and IL-10) in the circulating blood tended to be higher with aging in both CLP and LPS models, and in particular, the induction of IL-6 was significantly augmented with aging. The serum level of IL-6 showed a strong correlation with degrees of hypothermia. In the heart and lungs, the induction of mRNA for IL-6 and IL-10 was also significantly enhanced with aging. These results clearly demonstrate an age-associated increase in mortality, hypothermia, and induction of IL-6 during endotoxemia and sepsis. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1047 / 1058
页数:12
相关论文
共 48 条
  • [1] IL-6 AND NF-IL6 IN ACUTE-PHASE RESPONSE AND VIRAL-INFECTION
    AKIRA, S
    KISHIMOTO, T
    [J]. IMMUNOLOGICAL REVIEWS, 1992, 127 : 25 - 50
  • [2] An MR, 1996, MOL CELL BIOL, V16, P2295
  • [3] Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
    Angus, DC
    Linde-Zwirble, WT
    Lidicker, J
    Clermont, G
    Carcillo, J
    Pinsky, MR
    [J]. CRITICAL CARE MEDICINE, 2001, 29 (07) : 1303 - 1310
  • [4] PROTECTIVE ROLE OF INTERLEUKIN-6 IN THE LIPOPOLYSACCHARIDE-GALACTOSAMINE SEPTIC SHOCK MODEL
    BARTON, BE
    JACKSON, JV
    [J]. INFECTION AND IMMUNITY, 1993, 61 (04) : 1496 - 1499
  • [5] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    [J]. CHEST, 1992, 101 (06) : 1644 - 1655
  • [6] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [7] SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION
    CHOMCZYNSKI, P
    SACCHI, N
    [J]. ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) : 156 - 159
  • [8] Chorinchath BB, 1996, J IMMUNOL, V156, P1525
  • [9] CYTOKINE SERUM LEVEL DURING SEVERE SEPSIS IN HUMAN IL-6 AS A MARKER OF SEVERITY
    DAMAS, P
    LEDOUX, D
    NYS, M
    VRINDTS, Y
    DEGROOTE, D
    FRANCHIMONT, P
    LAMY, M
    [J]. ANNALS OF SURGERY, 1992, 215 (04) : 356 - 362
  • [10] Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I - A model for stunted growth in children with chronic inflammation
    DeBenedetti, F
    Alonzi, T
    Moretta, A
    Lazzaro, D
    Costa, P
    Poli, V
    Martini, A
    Ciliberto, G
    Fattori, E
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (04) : 643 - 650